Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation

Molecular and Cellular Biology

Volumn 22, Issue 14, 2002, Pages 5100-5113

  Bajenaru, Michaela Livia ^a   Zhu, Yuan ^a   Hedrick, Nicolé M ^a   Donahoe, Jessica ^a   Parada, Luis F ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; NEUROFIBROMIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; GROWTH REGULATION; KNOCKOUT MOUSE; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, NEUROFIBROMATOSIS 1; GENES, REPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTEGRASES; LAC OPERON; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; VIRAL PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0036293742     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.14.5100-5113.2002     Document Type: Article

References (48)

1. 3H-glutamate by primary astrocyte cultures. II. Differences in cultures prepared from different brain regions
2. Site-specific recombination mediated by an adenovirus vector expressing the cre recombinase protein: A molecular switch for control of gene expression
3. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes
4. The NF1 focus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
5. Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients
6. Regulators and effectors of ras proteins
7. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
8. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
9. GFAP transgenic mice
10. A major segment of the neurofibromatosis 1 gene: cDNA sequence, genomic structure and point mutations
11. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas
12. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
13. Astrocyte-specific expression of activated Ras results in malignant astrocytomas in a transgenic mouse model of human gliomas
14. Distinctive growth patterns between cerebral and cerebellar astrocytomas - A tissue culture study
15. The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas
16. Identification of the neurofibromatosis type 1 gene product
17. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation
18. Loss of neurofibromatosis 1 (NF1)-associated pilocytic astrocytomas
19. Comparative gene expression profile analysis of neurofibromatosis 1 (NF1)-associated and sporadic pilocytic astrocytomas
20. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro
21. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development
22. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity by using a p53 functional assay
23. Tumor predisposition in mice heterozygous for a targeted mutation in NF1
24. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas
25. Genomic targeting with an MBP-Cre fusion protein
26. Pten regulates neuronal soma size: A mouse model of Lhermitte-Duclos disease
27. Loss of neurofibromin is associated with activation of the RAS/MAPK and PI3-K/AKT signaling in neurofibromatosis 1 astrocytoma
28. Astrocytes exhibit regional specificity in gap-junction coupling
29. Cancer related gene expression in neurofibromatosis 1 (NF1)-associated pilocytic astrocytomas
30. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force
31. Z/AP, a double reporter for cre-mediated recombination
32. Induction of medulloblastomas in p53-null mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
33. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
34. Neurofibromin expression and astroglinsis in neurofibromatosis (type 1) brains
35. Expression of the neurofibromatosis 1 (NF1) tumor suppressor gene product, neurofibromin, during growth arrest in fibroblasts
36. Upregulation of specific NF1 gene transcripts in sporadic pilocytic astrocytomas
37. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
38. Analysis of pilocytic astrocytomas by comparative genomic hybridization
39. Efficient liver-specific deletion of a floxed human angiotensin transgene by adenoviral delivery of Cre recombinase in vivo
40. Deletions and translocation interrupt a cloned gene at the neurofibromatosis 1 locus
41. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in NF1 patients
42. Nonrandom chromosomal gains in pilocytic astrocytomas of childhood
43. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae
44. Dual fluorescent in situ hybridization and immunohistochemical detection with tyramide signal amplification
45. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases
46. Ablation of NF1 function in neurons induces abnormal development of the cerebral cortex and reactive gliosis in the brain